1. Home
  2. BNR vs MBOT Comparison

BNR vs MBOT Comparison

Compare BNR & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • MBOT
  • Stock Information
  • Founded
  • BNR 2014
  • MBOT 2010
  • Country
  • BNR China
  • MBOT United States
  • Employees
  • BNR N/A
  • MBOT 22
  • Industry
  • BNR Medical Specialities
  • MBOT Medical/Dental Instruments
  • Sector
  • BNR Health Care
  • MBOT Health Care
  • Exchange
  • BNR Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • BNR 61.7M
  • MBOT 50.4M
  • IPO Year
  • BNR 2020
  • MBOT N/A
  • Fundamental
  • Price
  • BNR $5.66
  • MBOT $1.45
  • Analyst Decision
  • BNR
  • MBOT Strong Buy
  • Analyst Count
  • BNR 0
  • MBOT 1
  • Target Price
  • BNR N/A
  • MBOT $9.00
  • AVG Volume (30 Days)
  • BNR 5.3K
  • MBOT 3.0M
  • Earning Date
  • BNR 03-27-2025
  • MBOT 03-26-2025
  • Dividend Yield
  • BNR N/A
  • MBOT N/A
  • EPS Growth
  • BNR N/A
  • MBOT N/A
  • EPS
  • BNR N/A
  • MBOT N/A
  • Revenue
  • BNR $72,832,704.00
  • MBOT N/A
  • Revenue This Year
  • BNR $52.90
  • MBOT N/A
  • Revenue Next Year
  • BNR $48.35
  • MBOT N/A
  • P/E Ratio
  • BNR N/A
  • MBOT N/A
  • Revenue Growth
  • BNR N/A
  • MBOT N/A
  • 52 Week Low
  • BNR $0.57
  • MBOT $0.82
  • 52 Week High
  • BNR $8.99
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • BNR 40.71
  • MBOT 41.27
  • Support Level
  • BNR $4.41
  • MBOT $1.25
  • Resistance Level
  • BNR $6.33
  • MBOT $1.48
  • Average True Range (ATR)
  • BNR 0.54
  • MBOT 0.14
  • MACD
  • BNR -0.16
  • MBOT -0.04
  • Stochastic Oscillator
  • BNR 35.82
  • MBOT 24.39

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Share on Social Networks: